Form 4: AtriCure CEO Michael Carrel Acquires Shares Through Employee Stock Purchase Plan

AtriCure's CEO, Michael Carrel, acquired 707 shares of common stock through the company's Employee Stock Purchase Plan (ESPP) at a discounted price of $19.35 per share.

Summary

• Michael Carrel, the President, CEO, and Director of AtriCure, Inc., acquired 707 shares of common stock on June 28, 2024.
• The shares were purchased through the AtriCure, Inc. 2018 Employee Stock Purchase Plan (ESPP) for the period ended June 30, 2024.
• The purchase price was $19.35 per share, which is 85% of the closing price of AtriCure's common stock on June 28, 2024 ($22.77).
• Following the transaction, Carrel directly owns 656,239 shares of AtriCure common stock.
• Carrel also indirectly owns 5,310 shares held by his children and 2,250 shares held by his parents, but he disclaims beneficial ownership except for his pecuniary interest.

Sentiment

Score: 6

Explanation: Neutral sentiment. The transaction is a routine purchase under the ESPP, indicating confidence but not necessarily a major shift in outlook.

Positives

• The CEO's participation in the ESPP demonstrates confidence in the company's future.

Industry Context

Insider transactions are common, and closely watched, indicators of management's sentiment regarding the company's prospects. Purchases, especially by top executives, are often seen as a positive sign.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholder sentiment due to the CEO's increased investment in the company.

Key Dates